Stay updated with breaking news from Biological E. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
The southern hemisphere is not vaccinated? and to that i say, look, the mrna vaccines were never intended to vaccinate the world with a brand-new technology you just cannot make enough of it and that's why where our vaccine comes in, a low cost similar levels of protection, easily accessible vaccine that there's no limit to the amount you can scale and so we've been frustrated not having more help from the u.s. government and the international bodies on our own, we've been scaling up production with biological e, an amazing organization in india and bio pharma in indonesia, but that's the answ...
Union Health Minister Mansukh Mandaviya took to his official Twitter account and wrote that India has 'expanded its vaccine basket'.
Read more about Opportunity for potential vaccine entrants in India shrinking: Analysts on Business Standard. The government has recently set the maximum price that private hospitals can charge for the three Covid-19 vaccines currently available in India
By the end of 2021, India might have access to 6 COVID-19 vaccines, all in the pipeline and being locally developed.